Autoimmune Hepatitis: 2019 Practice Guidance and Guidelines

Autoimmune hepatitis (AIH) is an autoimmune-mediated attack of the liver cells, with a prevalence of 3 out of 100,000 cases among children. In 2018 and 2019, adult and pediatric hepatologists convened to work on updating the American Association for the Study of Liver Diseases (AASLD) Practice Guidelines for the diagnosis and management of autoimmune hepatitis. Watch this video to learn more about the 2019 AASLD guidelines from Cara L. Mack, MD, Medical Director of the Pediatric Liver Center, who chaired this initiative.

In this video, Dr. Mack reviews the 2019 AASLD guidelines, which include recommendations for the most effective first-line treatment therapies for AIH, use of second-line therapies and long-term use of steroids after liver transplant for AIH. She also discusses future directions and unmet needs for the management of AIH as well as potential future therapies.

Connect with Children’s Colorado:

[ssematakasaanapacific]

What can I do Ihave Autoimmune apatitis